BOA2018 Palliative Care

The care of patients with metastatic cancers is a substantial component of care in radiation oncology settings. Palliative care in radiation oncology has often been a neglected area of clinical research. Clinical research is needed – with immediate translation into clinical practice – to improve the care of this of this diverse patient population. This session will address is reviewing recent evidence to guide and improve clinical practice in the care of patients with advanced malignancies.

Target Audience

The meeting is designed to meet the interests of radiation oncologists.

Learning Objectives

  • Discuss current research advances in palliative care/radiation oncology.
  • Apply novel radiotherapeutic modalities in palliative care/radiation oncology.
  • Explain the importance of research/advancement in palliative care/radiation oncology.
     
Course summary
Available credit: 
  • 1.00 Certificate of Attendance
    This activity was designated for 1.00 AMA PRA Category 1 Credit™.
  • 1.00 SA-CME

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.

    The American Society for Radiation Oncology (ASTRO) designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.00 self-assessment credits.

Course opens: 
11/16/2018
Course expires: 
12/14/2018
Cost:
$0.00
Rating: 
0

Tracy Balboni, MD, MPH is employed by Brigham and Women's Physician's Organization, receives  compensation/remuneration/funding from Templeton Foundation, and holds a leadership position in ASCO.

Alexander Lin, MD  is employed by the University of Pennsylvania and receives compensation/remuneration/funding from NIH.
 

The person(s) above served as the developer(s) of this activity. Additionally, Education Committee and CME/MOC Committee had control over the content of this activity.

Disclosure link: 
Education Committee and the CME-MOC Committee

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.

ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification. 

Available Credit

  • 1.00 Certificate of Attendance
    This activity was designated for 1.00 AMA PRA Category 1 Credit™.
  • 1.00 SA-CME

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.

    The American Society for Radiation Oncology (ASTRO) designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.00 self-assessment credits.

Price

Cost:
$0.00
Please login or register to take this course.

Policies: 

  • No refunds, extensions or substitutions will be made for those registrants who, for any reason, were unable to attend or were tardy for the session.
  • No credits will be granted and no refunds, exchanges or transfers will be given to those who do not pass.
  • ASTRO staff cannot make modifications to your submitted materials.
     

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.